Advertisement

Topics

Latest "Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study" News Stories

01:49 EST 22nd January 2019 | BioPortfolio

Here are the most relevant search results for "Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study" found in our extensive news archives from over 250 global news sources.

More Information about Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study for you to read. Along with our medical data and news we also list Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study Clinical Trials, which are updated daily. BioPortfolio also has a large database of Use Of New Supraglottic Airway Devices In Severely Obese Patients: A Feasibility Study Companies for you to search.

Showing "Supraglottic Airway Devices Severely Obese Patients Feasibility Study" News Articles 1–25 of 39,000+

Tuesday 22nd January 2019

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program


New Device that can Rapidly Diagnose Disease Could Save Lives

MELBOURNE, Australia, Jan. 22, 2019 /PRNewswire/ -- Monash University biospectroscopists have been issued a US patent for the diagnostic technology they hope will one day help doctors to diagnose and treat patients much faster than current pathology methods. Scientists have developed a new device that can rapidly screen the blood in just minutes to detect a range of pathogens that cause disease, ...

Updated Analysis of Pivotal Study Reveals: Proactive, High Dosage of Venofer® Significantly Reduces Risk of Death or Major Cardiovascular Events in Haemodialysis Patients

Re-analysis of the PIVOTAL data by the investigators has revealed that proactive, high-dose Venofer® compared to reactive, low-dose Venofer® resulted in: Superiority and statistically significant reduction in the risk of death or major cardiovascular events (P=0.04) Fewer myocardial infarctions or fewer hospitalisations...


Monday 21st January 2019

Almac Diagnostic Services Ltd Product Pipeline Analysis, 2018 Update [Report Updated: 13122018] Prices from USD $750

SummaryAlmac Diagnostic Services Ltd Almac Diagnostic Services, a subsidiary of Almac Group Ltd, is a medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company provides products pipeline such as ColDx, DDRD, AADx, prostate Dx and MEK Dx, among others. It offers ColDx, a prognostic assay for stage II and III colon cancer, an...

Golden staph on the rise in Vic and WA communities

While the number of golden staph (Staphylococcus aureus) infections in hospitals have declined over the last few years, the number of infections acquired outside hospitals are on the rise. The infections increased in the community by 8% and 6% a year in Victoria and Western Australia respectively from the start of 2011 to the end of 2016, according to the Medical Journal of Australia. Despite a ...

Rising temperatures may safeguard crop nutrition as climate changes

(Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign) Recent research has shown that rising carbon dioxide levels will likely boost yields, but at the cost of nutrition. A new study in Plant Journal suggests that this is an incomplete picture of the complex environmental interactions that will affect crops in the future -- and rising temperatures may actually be...

Widely available food in US workplaces: Perk or hazard?

(Elsevier) Nearly a quarter of employed adults obtain foods and beverages at work at least once a week, according to a new study from the US Centers for Disease Control and Prevention (CDC) and published in the Journal of the Academy of Nutrition and Dietetics. Foods obtained at work are often high in calories, refined grains, added sugars, and sodium.

Possible Oahu populations offer new hope for Hawaiian seabirds

(American Ornithological Society Publications Office) The two seabird species unique to Hawaii, Newell's shearwaters and Hawaiian petrels, are the focus of major conservation efforts -- at risk from habitat degradation, invasive predators, and other threats, their populations plummeted 94 percent and 78 percent respectively between 1993 and 2013. However, a new study in The Condor: Ornithological ...

Which Type Of Insomniac Are You? Study Suggests Different Sleep Problems Require Different Solutions

Insomnia affects millions of people every night, and often the solutions proposed to help sufferers do little or nothing. New research suggests that we need new ways of looking at the problem.

[Articles] Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Multiple sclerosis is not common but is a potentially severe cause of neurological disability throughout adult life. Prevalence has increased substantially in many regions since 1990. These findings will be useful for resource allocation and planning in health services. Many regions worldwide have few or no epidemiological data on multiple sclerosis, and more studies are needed to make more accura...

Mortality from Medical Harm Falls Steadily

The rate of mortality due to medical harm has fallen modestly since 1990, according to a study in JAMA Network Open. Using an analysis of...

Graybug Vision Presents Top Line Results of Phase 1/2a ADAGIO Study at Hawaiian Eye & Retina 2019

ADAGIO Study Provides Evidence that GB-102 Can Achieve Sustained-Drug Delivery in the Treatment of Wet Age-Related Macular Degeneration (AMD) Graybug Vision’s novel investigational depot approach is designed to continuously inhibit activity of all VEGF receptors for the treatment of wet AMD GB-102 was well-tolerated w...

Aurinia to Hold Conference Call and Webcast to Discuss Results of Phase 2 Head-to-Head Study of Voclosporin Ophthalmic Solution versus Restasis® for the Treatment of Dry Eye Syndrome

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced it will report results before the opening of trading and hold a webcast and conference call to discuss the results of its Phase 2, double-masked, head-to-head study of VOS 0.2% versus Restasis® (cyclospori...

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2018 results after the financial markets close on Tuesday, February 26, 2019. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time)...

DBT reduces recall rates, number of patients for short-term follow up

Implementing three-dimensional (3D) digital breast tomosynthesis (DBT) with standard digital mammography (DM) can reduce the number of patients committed to short-term follow-up screening, according to research published online Jan. 19 in Academic Radiology.

Alert dogs for T1D show promise in detecting owners’ blood sugar changes

Trained “glycemia alert dogs” are more reliable in signaling out-of-range (OOR) blood sugar levels to their owners with type 1 diabetes than previously reported, according to a new study published in PLOS One.

imaware Launches At-Home Celiac Disease Monitoring Test

People can now monitor and trend immune system response to their gluten-free diet from the comfort of home HOUSTON (PRWEB) January 21, 2019 imaware(TM), an at-home testing platform for chronic illness and diseases designed by healthcare company Microdrop, today announced it has expanded its line of tests for people with Celiac Disease. The platform now includes an easy-to-use monitoring test for ...

PFS Benefit Confirmed With Daratumumab Plus VMP in Newly Diagnosed Myeloma

Maria-Victoria Mateos, MD, PhD, discusses the updated findings from the ALCYONE trial in patients with newly diagnosed multiple myeloma.

Is noncontrast head CT the right choice for patients with severe headaches?

Noncontrast head CT (NCCN) for patients with severe headaches provides little value when no other obvious "red flags" are present, according to a new study published in the Journal of the American College of Radiology.

Breast MRI may help personalize treatment for DCIS patients

Pairing breast MRI with a test that characterizes breast cancer genes can lead to a more personalized treatment approach for patients with ductal carcinoma in situ (DCIS), reported authors of a recent study published in JAMA Oncology.

Where Apple will likely invest in healthcare

All signs point to technology giant Apple continuing its dive into the healthcare space with new services or devices. With its recent foray into health monitoring through its Apple Watch, the company is poised to make a splash in other areas, Fast Company predicted.

NCI Moves to Expand Clinical Trial Eligibility Criteria

In en effort to ensure that study participants are more reflective of real-world populations, the National Cancer Institute has revised its clinical trial protocols to expand access for previously excluded patients.

2 hours in the ER enough to rule out risky arrhythmias in most syncope patients

The majority of patients who present to the emergency department (ED) after fainting likely don’t need to be monitored for more than two hours to rule out any dangerous underlying arrhythmias, Canadian researchers have found.

Proteus Digital Health® Founder to Present at World Economic Forum in Davos

Proteus Digital Health® announced today that Andrew Thompson, its President, Chief Executive Officer and Co-Founder, will present on the progress of Proteus’ digital medicines to improve patient treatment and outcomes at the 2019 World Economic Forum Annual Meeting in Davos-Klosters, Switzerland. Mr. Thompson will present on the official progra...

Cancer survivors face stress from steep medical bills

(Reuters Health) - Cancer survivors have higher-than-average rates of medical financial hardship, a U.S. study suggests.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks